Stefani Wolff

Insider Reports History

Entity
Individual
Location
C/O Principia Biopharma Inc., 400 East Jamie Court, Suite 302, South San Francisco, CA
Signature
/s/ Ryan Murr, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stefani Wolff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. EVP and COO Restricted Stock Units 10.6K $84.6K $7.99 Apr 30, 2023 Direct
Nurix Therapeutics, Inc. EVP and COO Common Stock 6.11K $61.1K $10.00 May 1, 2023 Direct
Rain Oncology Inc. Director Stock Option (Right to Buy) 0 Jan 26, 2024 Direct

Insider Reports Filed by Stefani Wolff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAIN Rain Oncology Inc. Jan 26, 2024 3 $0 4 Jan 26, 2024 Director
RAIN Rain Oncology Inc. Aug 9, 2023 1 $0 4 Aug 11, 2023 Director
NRIX Nurix Therapeutics, Inc. Apr 30, 2023 3 -$3.38K 4 May 2, 2023 EVP and COO
NRIX Nurix Therapeutics, Inc. Feb 14, 2023 2 $0 4 Feb 15, 2023 EVP and COO
NRIX Nurix Therapeutics, Inc. Jan 30, 2023 3 -$4.99K 4 Feb 1, 2023 EVP and COO
NRIX Nurix Therapeutics, Inc. Oct 30, 2022 3 -$4.51K 4 Nov 1, 2022 EVP and COO
NRIX Nurix Therapeutics, Inc. Aug 9, 2022 1 $0 4 Aug 10, 2022 EVP and COO
NRIX Nurix Therapeutics, Inc. Jul 30, 2022 3 -$5.58K 4 Aug 2, 2022 EVP and COO
RAIN Rain Therapeutics Inc. Jun 1, 2022 1 $0 4 Aug 19, 2022 Director
NRIX Nurix Therapeutics, Inc. Apr 30, 2022 3 -$3.88K 4 May 3, 2022 EVP and COO
NRIX Nurix Therapeutics, Inc. Jan 19, 2022 2 $0 4 Jan 21, 2022 EVP and COO
NRIX Nurix Therapeutics, Inc. Aug 16, 2021 0 $0 3 Aug 17, 2021 EVP and COO
RAIN Rain Therapeutics Inc. May 14, 2021 1 $0 4 May 18, 2021 Director